GIC Re Rs 3,088 Crore OFS: Should Retail Investors Participate?
The General Insurance Corporation of India (GIC Re) is back in the spotlight as its ₹3,088 crore Offer for Sale (OFS) opens for retail investors on Wednesday, June 17. Following a highly successful day for institutional bidders, the market is now closely watching whether individual investors should seize this opportunity.
Understanding the OFS Structure and Demand
The government’s disinvestment plan aims to sell up to a 5% equity stake in the state-run reinsurer. The base offer consists of 3.51 crore shares (a 2% stake), with the government exercising the "green shoe" option to sell an additional 5.26 crore shares (a 3% stake). This brings the total offering to 8.77 crore shares.
The floor price for the OFS is set at ₹352 per share, which represents a 2% discount to the stock’s previous closing price. Early indicators suggest strong institutional interest; on the first day of bidding for non-retail investors, the issue was already oversubscribed 3.72 times.
Analyst Caution: Profitability and Sector Headwinds
Despite the robust demand from institutions, market experts are urging retail investors to exercise caution. Analysts from SBI Securities have advised skipping the subscription, citing fundamental concerns regarding GIC Re's operational efficiency.
A primary concern is the company's "combined ratio," which stood at 106% for FY26. While this is an improvement from 109% in FY23, a ratio above 100% indicates that the company is paying out more in claims and expenses than it is earning in premiums. Consequently, GIC Re is heavily reliant on its massive investment portfolio—valued at approximately ₹1.5 lakh crore as of FY26—to drive its bottom-line profits. Furthermore, the reinsurance industry is currently battling intense pricing pressure and heightened competition.
Stock Performance and Valuation
The market reaction to the OFS has been tepid for the stock itself. GIC Re shares tumbled over 7% on Tuesday following the announcement, contributing to a broader decline of 6% over the past week. The stock has struggled in 2026, down nearly 6% year-to-date.
С точки зрения оценки стоимости, бизнес торгуется с расчетным коэффициентом цена/балансовая стоимость (P/B) на 2026 финансовый год (FY26) на уровне 1,2x (без учета изменений справедливой стоимости) при рентабельности собственного капитала (RoE) 16,4%. Хотя долгосрочная траектория была положительной — с ростом на 88% за три года — краткосрочные перспективы остаются неопределенными из-за трудностей компании с обеспечением стабильной операционной прибыли.
Основные выводы
- Высокий интерес институциональных инвесторов: В рамках OFS наблюдался огромный ранний спрос: институциональные инвесторы переподписали начальный транш в 3,72 раза.
- Операционные риски: Аналитики предупреждают о высоком комбинированном коэффициенте (106% на FY26), что означает, что для поддержания прибыльности компания полагается на инвестиционный доход, а не на андеррайтинговую прибыль.
- Стратегия для розничных инвесторов: Учитывая ценовое давление в секторе перестрахования и недавнюю нисходящую тенденцию акций, многие эксперты рекомендуют розничным инвесторам воздержаться от участия в текущем OFS.